pcos treatment glp-1 Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? | Journal of Endocrinological Investigation The Role of Glp-1 Receptor

The GLP-1 Support Box ($109) is designed to make nourishment easier when hunger cues are low, with protein- and fiber-rich fruit- and vegetable-forward options that are simple to consume and gentle on digestion

Phase 2 Trial Design Participants: 338 adults with obesity (BMI 30) or overweight with comorbidities (BMI 27), without diabetes Duration: 48 weeks Dosing groups: Placebo, 1mg, 4mg, 8mg, or 12mg weekly (with gradual dose escalation over 20-24 weeks) Primary endpoint: Percentage change in body weight from baseline Beyond Weight Loss: Metabolic Improvements Beyond weight loss, the 12mg dose also improved several cardiometabolic markers: Blood pressure: Systolic BP decreased by 7.4 mmHg (clinically significant reduction) Lipids: Triglycerides fell 30%, HDL cholesterol increased 8% Glucose control: HbA1c decreased 0.4% even in participants without diabetes Liver health: Markers of fatty liver disease (ALT, AST) improved significantly Inflammation: C-reactive protein (CRP) decreased, indicating reduced systemic inflammation What this means: Retatrutide appears to improve the metabolic dysfunction behind obesity-related diseases, not just the weight itself

In a consumer study of 274 people taking GLP-1 Probiotic for 6 weeks, 91% reported reduced food cravings

It will be very hard to estimate the precise impact

Most daily activities feel manageable

The human GCGR gene was cloned into pFastBac1 vector with GP64 promoter at the N terminus to enhance the protein yield